Terms of Use

This website (the "Website") is operated by GNI Group Ltd. ("Company"). Please read the following terms of use (the "Terms of Use") thoroughly before using the Website. By using the Website, you are deemed to agree to the following Terms of Use. These Terms of Use are subject to change without notice. Please confirm the updated version of the Terms of Use when you use the Website.

1. Copyright

All the contents of the Website including documents, photographs, illustrations, images, videos, sounds and programs are protected by copyright and other applicable laws and regulations of each nation and applicable treaties. You are forbidden to use, duplicate or modify these contents for any purposes other than non-commercial personal use without the approval of right holders.

2. Trademark rights and other rights

Trademarks, service marks, trade names and designs (collectively, “Trademarks”) indicated on the Website are protected by the law. You are forbidden to use the Trademarks without authorization or otherwise infringe any rights to the Trademarks.

3. Disclaimer

Company takes every precaution regarding information posted on the Website. However, Company does not guarantee accuracy, reliability, usability, timeliness or completeness of the contents on the Website. Company and its subsidiaries and affiliate companies (collectively, the “Subsidiaries”) shall not be liable for any damages arising out of the use of, access to or inability to access to the Website.

Company shall not be liable for any interruption of the features of the Website, errors, computer virus or any other detriment.

Company posts information on the Website not for investment solicitation, but for the purpose of public announcements. Please make your investments on your own judgment.

4. Medical information

The Website provides general information on diseases, etc. and information on the pharmaceutical products (including those under research or development) that Company or any of its Subsidiaries researches, develops, manufactures or sells. The Website does not provide any advice to be provided by doctors or other medical personnel or any information to be substituted for such advice.

The Website specifies the applicable laws based on which the descriptions are provided regarding pharmaceutical products and researches, developments, manufactures or sales of such products. The information posted on the Website may be inappropriate in nations other than those applying such laws. Please confirm the requirements and details of approvals, permissions and other regulations for the products in each nation.

5. Earnings expectations

Information on Company or Subsidiaries (including information on their business performances) posted on the Website may include earnings expectations prepared or calculated based on prospects, expectations, risks or other uncertain factors at the time of preparation or calculation. Actual business performances in the future may be different from such earnings expectations subject to changes of economic conditions, and progress of research and development, sales or manufactures.

6. Silent period

To prevent unauthorized release of earnings information and ensure fairness, the Company observes a "silent period" from the last day of each closing date of quarterly earnings until the date on which each set of financial results is announced. During the silent period, as a rule, the company refrains from responding to questions regarding its financial results and from making related comments. However, in the event that during the silent period it becomes clear to the Company management that results are likely to differ substantially from forecasts previously disclosed, the company will effect an information disclosure in accordance with the Rules on Timely Disclosure in principle. Besides, Company will respond to inquiries even during the silent period regarding the information already made public.

7. Contact by e-mail or other communication methods

Any information other than personal information transmitted to Company or Subsidiaries by email or other communication methods may not be treated as confidential (Please see our Privacy Policy regarding treatment of personal information). Company and Subsidiaries shall not be obliged to respond to anyone who contacts Company or Subsidiaries by email or any other communication methods. Company and Subsidiaries shall not be liable for any information provided by emails or any other communication methods and may use such information freely for any purposes. Company and Subsidiaries shall not be obliged to respond to a question on any information on Company or Subsidiaries provided by a third party (including information indicated or posted by a third party on a website or other media that provides information on investments, stocks, companies, etc.)

8. Links to and from the Website

If you wish to establish a link to the Website, please obtain Company’s prior approval. Company has no authority over a third party’s website linking to the Website or a third party’s website to which the Website is linking (collectively, "Linked Websites"). Company shall not be liable for any contents or use of Linked Websites. If you use Lined Websites, please comply with the terms of use of such Linked Websites.

9. Modification of the Website

Company may modify the contents on the Website without notice or may discontinue operation of the Website.

10. English version of the Website

In principle, the information posted on the English version of the Website is English translation of the Japanese version of the Website. However, the English version may contain only English summaries of the Japanese version. In the event that there is an inconsistency between Japanese and English versions, the Japanese version shall prevail over the English version.

11. Information transmitted through social media, etc.

Information transmitted through social media or other media by employees or other related parties of Company or its Subsidiaries shall not be deemed as official announcement or official view of Company or its Subsidiaries. Please see the Website or the websites of Subsidiaries to confirm the official announcements or official views of Company or Subsidiaries.

12. Reproduction of Company’s view, etc.

If you transmit through a website, social media or any other media a copy or modification of a response (in writing, by email, verbally or by any other means) from Company or Subsidiaries to a question, opinion or any other communication given by a user of the Website, you may violate the Copyright Act, the Financial Instruments and Exchange Act or other laws. Company or Subsidiaries shall not be liable for any information on Company or Subsidiaries transmitted by a third party.

13. Governing law

Japanese Law shall govern the use of the Website and interpretation and application of these Terms of Use. The Tokyo District Court shall have exclusive jurisdiction of the first instance over any and all disputes arising out of or relating to the use of the Website.

14. Recommended viewing environment

  • Internet Explorer 10 or later
  • Google Chrome latest version
  • Mozilla Firefox latest version
  • Opera latest version
  • Safari latest version